Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
A study that looks into the potential of wearables to non-invasively measure blood glucose has come up with promising results ...
Zacks.com on MSN2d
DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 ApprovalDexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The ...
First for Women on MSN8d
MDs Share 5 Things To Know About Blood Sugar Monitors—Even if You Don't Have DiabetesThe latest trend in health and fitness tracking may sound familiar: wearing continuous glucose monitors (CGMs). Many people ...
CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.
will ingest glucose data from Dexcom G7 Continuous Glucose Monitoring Systems (CGM) time synchronously alongside Nanowear’s previously FDA cleared cardiovascular biomarkers. The continuous ...
AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.
Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSense™, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results